Swedesboro-based Wedgewood Pharmacy has agreed to acquire a licensed outsourcing facility in California, as well as a veterinary compounding pharmacy in Wyoming, it announced Thursday.
The company said the first deal involves the assets of Colorado-based Leiters Enterprises, which owns a 22,000-square-foot 503B facility in San Jose that is licensed in 45 states. The business will now operate as Wedgewood Connect, and begin releasing preparations in the fourth quarter. The transaction is expected to close by June 30.
“We believe that our ability to offer preparations from both a 503B outsourcing facility as well as our traditional state-regulated pharmacies will give our customers a broader range of options designed to meet their specific needs,” Wedgewood CEO and President Marcy Bliss said in a prepared statement. “This capability will further our mission of improving the lives of animals and those who love them.”
The second deal involves Wildlife Pharmaceuticals Inc., based in Windsor, Colorado, and its wholly owned subsidiary, ZooPharm, based in Laramie, Wyoming. The companies serve veterinarians and patients in the wildlife and zoo markets, and Wedgewood intends to maintain the ZooPharm brand. The transaction is expected to close within 90 days.
“We are honored to carry on the legacy started by (Wildlife Pharmaceuticals CEO) Dr. Bill Lance in his quest to increase the care and survival of wildlife and zoo species,” Bliss said.
Both deals are pending customary approvals and conditions. Financial terms were not disclosed.
Wedgewood is the largest animal health compounding pharmacy in the nation, and also serves the human health market.